We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B Turnover 22.5%
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+13.79%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.82B
AUM Growth
+$522M
Cap. Flow
+$73.4M
Cap. Flow %
1.52%
Top 10 Hldgs %
20.44%
Holding
604
New
109
Increased
179
Reduced
173
Closed
43
Avg Time Held
0.2 years
Top 10 Avg Time Held
0.1 years
Top 20 Avg Time Held
0.2 years

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$48.8M
2
CMCSA icon
Comcast
CMCSA
+$46.9M
3
AVY icon
Avery Dennison
AVY
+$38.5M
4
MIDD icon
Middleby
MIDD
+$33M
5
LKQ icon
LKQ Corp
LKQ
+$32.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.65%
2 Financials 14.81%
3 Industrials 14.31%
4 Technology 11.57%
5 Energy 10.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LLY icon
226
Eli Lilly
LLY
$1.12T
$1.02M 0.02%
20,327
-253
-1% -$13.2K
2013 Q2
1 quarter
ALGN icon
227
Align Technology
ALGN
$10.6B
$1.02M 0.02%
21,210
+7,895
+59% +$345K
2013 Q2
1 quarter
FIVE icon
228
Five Below
FIVE
$12.3B
$1.02M 0.02%
+23,230
New +$932K
2013 Q3
0 quarters
BLK icon
229
Blackrock
BLK
$174B
$1M 0.02%
3,703
+25
+0.7% +$6.79K
2013 Q2
1 quarter
SPLK icon
230
DELISTED
Splunk Inc
SPLK
$977K 0.02%
16,265
+4,220
+35% +$225K
2013 Q2
1 quarter
SIRO
231
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
$966K 0.02%
14,437
-13,349
-48% -$901K
2013 Q2
1 quarter
ABBV icon
232
AbbVie
ABBV
$501B
$952K 0.02%
21,276
-2,088
-9% -$92.6K
2013 Q2
1 quarter
CVS icon
233
CVS Health
CVS
$118B
$945K 0.02%
16,651
-1,562
-9% -$93.1K
2013 Q2
1 quarter
IVV icon
234
iShares Core S&P 500 ETF
IVV
$889B
$945K 0.02%
5,593
+29
+0.5% +$4.89K
2013 Q2
1 quarter
WFT
235
DELISTED
Weatherford International plc
WFT
$940K 0.02%
+61,350
New +$900K
2013 Q3
0 quarters
EW icon
236
Edwards Lifesciences
EW
$50.8B
$936K 0.02%
80,616
-7,650
-9% -$89.5K
2013 Q2
1 quarter
MDY icon
237
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.6B
$935K 0.02%
4,133
-80
-2% -$17.8K
2013 Q2
1 quarter
PBR icon
238
Petrobras
PBR
$163B
$929K 0.02%
+59,942
New +$854K
2013 Q3
0 quarters
TMO icon
239
Thermo Fisher Scientific
TMO
$258B
$929K 0.02%
10,085
+2,285
+29% +$207K
2013 Q2
1 quarter
ITW icon
240
Illinois Tool Works
ITW
$77.2B
$913K 0.02%
11,973
+689
+6% +$50.4K
2013 Q2
1 quarter
TLGT
241
DELISTED
Teligent, Inc
TLGT
$912K 0.02%
50,093
-1,657
-3% -$27.9K
2013 Q2
1 quarter
VIXY icon
242
ProShares VIX Short-Term Futures ETF
VIXY
$222M
$904K 0.02%
14
-2
-13% -$135K
2013 Q2
1 quarter
MMM icon
243
3M
MMM
$85.3B
$900K 0.02%
9,013
-1,512
-14% -$147K
2013 Q2
1 quarter
ALXN
244
DELISTED
Alexion Pharmaceuticals
ALXN
$894K 0.02%
7,695
-45
-0.6% -$4.94K
2013 Q2
1 quarter
AHT.PRD icon
245
Ashford Hospitality Trust Series D
AHT.PRD
$4.18M
$881K 0.02%
+34,890
New +$882K
2013 Q3
0 quarters
FCX icon
246
Freeport-McMoran
FCX
$101B
$875K 0.02%
26,445
+1,229
+5% +$37.6K
2013 Q2
1 quarter
LOW icon
247
Lowe's Companies
LOW
$110B
$854K 0.02%
17,933
+11,300
+170% +$513K
2013 Q2
1 quarter
ENV icon
248
DELISTED
ENVESTNET, INC.
ENV
$839K 0.02%
27,065
+8,655
+47% +$240K
2013 Q2
1 quarter
VOD icon
249
Vodafone
VOD
$36.7B
$835K 0.02%
23,293
-668
-3% -$21.1K
2013 Q2
1 quarter
ERF icon
250
DELISTED
Enerplus Corporation
ERF
$830K 0.02%
50,399
-2,045
-4% -$33.5K
2013 Q2
1 quarter

Similar funds

Geneva Advisors's Q3 2013 Portfolio in Review

As of Q3 2013, Geneva Advisors held 604 positions worth $4.82B, up 12% from $4.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneva Advisors's Q3 2013 filing shows 109 new, 179 increased, 173 reduced and 43 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 185,591 shares worth $58.1M. The largest sale was Monsanto Co, an estimated $63.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Geneva Advisors's largest Q3 2013 buy was Regeneron Pharmaceuticals: 185,591 shares worth $58.1M.
  • Geneva Advisors added most to Comcast in Q3 2013, an estimated $46.9M increase.
  • Geneva Advisors's biggest Q3 2013 reduction was Monsanto Co, cutting an estimated $63.1M.
  • Geneva Advisors fully exited Valmont Industries in Q3 2013, selling an estimated $36.7M.
  • Geneva Advisors's ten largest holdings make up 20% of its $4.82B portfolio in Q3 2013.
  • Geneva Advisors opened 109 new positions and closed 43 in Q3 2013.
  • Geneva Advisors's portfolio value rose 12% quarter-over-quarter to $4.82B.

Based on Geneva Advisors's 13F filing for Q3 2013, filed 4 Nov 2013.